Dr. Lal Path Labs Ltd. — Updates, 24-07-2026: General Updates
24-07-2026 | 01:45 pm
24-07-2026 | 01:45 pm
Board approved Q1 results: Revenue INR 797.7 Cr, Profit INR 169.5 Cr. Interim dividend declared at INR 5/share. Acquisitions include SDCPL for INR 20 Cr, 80% of Ghana's SHL for INR 38 Cr, and 30% of Neuome for INR 3.5 Cr.
No comments yet. Be the first to comment!
